Key Record Dates
| ClinicalTrials.gov Identifier: | NCT06246110 |
|---|---|
| Brief Title: | A Phase 2 Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Patients With Stage 4 Non-Small Cell Lung Cancer |
| First Submitted : | January 30, 2024 |
| First Submitted that Met QC Criteria : | January 30, 2024 |
| First Posted : | February 7, 2024 |
| Last Update Submitted that Met QC Criteria : | March 1, 2024 |
| Last Update Posted : | March 4, 2024 |